UNITY Biotechnology's Series B - II Round

UNITY Biotechnology raised a round of funding on August 17, 2017.

UNITY Biotechnology (NASDAQ: UBX), formerly Cenexys, designs therapeutics that prevent, halt, or reverse diseases of aging. The company's medicines are designed to lengthen healthspan, the amount of t…

Articles about UNITY Biotechnology's Series B - II Round: